Covid-19 manufacturing roundup: Moderna eyes Nexus' Wisconsin plant for vaccine boost; Catalent wraps up plant project
After an immediate demand for Covid-19 vaccines has opened back up following the CDC’s pause on J&J’s jab, Moderna is looking to boost production …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
